Purpose of the Review To provide an up-to-date review of the incidence of stroke and large
vessel occlusion (LVO) around the globe, as well as the eligibility and access to IV …

Stroke is the second highest cause of death globally and a leading cause of disability, with
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …

Following the success of recent endovascular trials, endovascular therapy has emerged as
an exciting addition to the arsenal of clinical management of patients with acute ischemic …

Stroke, a leading cause of death and long-term disability, has a considerable social and
economic impact. It is imperative to investigate stroke-related costs. The main goal was to …

Background The health economic benefit of endovascular treatment (EVT) in addition to best
medical management for acute ischemic stroke with large ischemic core is uncertain …

Objective To determine public health and cost consequences of time delays to endovascular
thrombectomy (EVT) for patients, health care systems, and society, we estimated quality …

Background The REVASCAT trial and other studies have shown that the neurovascular
thrombectomy improves outcomes at 90 days post stroke. However, whether the observed …

Background and Purpose: Tenecteplase improved functional outcomes and reduced the
requirement for endovascular thrombectomy in ischemic stroke patients with large vessel …

Background Neurocritical illness is a growing healthcare problem with profound
socioeconomic effects. We assessed differences in healthcare costs and long-term outcome …

Importance Two 2018 randomized controlled trials (DAWN and DEFUSE 3) demonstrated
the clinical benefit of mechanical thrombectomy (MT) more than 6 hours after onset in acute …